Abstract
Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.
| Original language | English |
|---|---|
| Pages (from-to) | 8-14 |
| Journal | International Journal of Cardiology |
| DOIs | |
| Publication status | Published - Jan 1 2018 |
Fingerprint
Keywords
- Clopidogrel
- Dual antiplatelet therapy
- Percutaneous coronary intervention
- Post-MI
- Secondary prevention
- Ticagrelor
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction : The EYESHOT Post-MI study. / EYESHOT Post-MI Investigators.
In: International Journal of Cardiology, 01.01.2018, p. 8-14.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction
T2 - The EYESHOT Post-MI study
AU - EYESHOT Post-MI Investigators
AU - De Luca, Leonardo
AU - Piscione, Federico
AU - Colivicchi, Furio
AU - Lucci, Donata
AU - Mascia, Franco
AU - Marinoni, Barbara
AU - Cirillo, Plinio
AU - Grosseto, Daniele
AU - Mauro, Ciro
AU - Calabrò, Paolo
AU - Nardi, Federico
AU - Rossini, Roberta
AU - Geraci, Giovanna
AU - Gabrielli, Domenico
AU - Di Lenarda, Andrea
AU - Gulizia, Michele Massimo
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.
AB - Aims: To describe the contemporary management by cardiologists of patients after an episode of myocardial infarction (MI). Methods: The EYESHOT Post-MI was a prospective, observational, nationwide study aimed to evaluate the management of patients referring to cardiologists 1 to 3 years from the last MI event. Results: Over a 3-month period, 1633 consecutive patients [median 22 (IQR 15–28) months from MI] were enrolled: 1028 (63.0%) at the second and 605 (37.0%) at the third year from MI. During the 12 months prior to enrolment, the majority of patients received a transthoracic echocardiogram (60% and 54%), followed by coronary angiography (24% and 16%, in the second and third year from MI groups, respectively). At the time of enrolment, the majority of patients were prescribed on statins (93%) and beta-blockers (82%), without significant differences between the 2 groups. A dual antiplatelet therapy (DAPT) was used more frequently among patients presenting during the second compared to the third year from MI (40% vs 24%; p < 0.0001). At multivariable analysis, the time interval from last MI (2 vs 3 years: OR 2.27; 95% CI 1.79–2.88; p < 0.0001) and a previous percutaneous coronary intervention with multiple stents (OR 3.46; 95% CI 2.19–5.47; p < 0.0001) resulted as the major independent predictors of DAPT persistence at the time of enrolment. Conclusions: This contemporary registry provides unique insights into the current management of post-MI patients and represents an opportunity to further improve the long-term treatment of this high-risk population.
KW - Clopidogrel
KW - Dual antiplatelet therapy
KW - Percutaneous coronary intervention
KW - Post-MI
KW - Secondary prevention
KW - Ticagrelor
UR - http://www.scopus.com/inward/record.url?scp=85052745675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052745675&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2018.08.055
DO - 10.1016/j.ijcard.2018.08.055
M3 - Article
AN - SCOPUS:85052745675
SP - 8
EP - 14
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
ER -